OrbiMed Capital GP VIII LLC

Director, Sionna Therapeutics, Inc.; 10% owner, Traws Pharma, Inc.

Bought, 12 months

$1.0M

Sold, 12 months

$5.2M

Companies

Latest trade

Jul 7, 2026

Companies

Sionna Therapeutics, Inc.Director −$5.2M Traws Pharma, Inc.10% owner +$1.0M

Trades

SION Sold 85,918 shares at $44.86 · planned $3.9M Jul 7

TRAW Bought 597,729 shares at $1.67 $1.0M Apr 16

SION Sold 29,063 shares at $44.58 · planned $1.3M Feb 3

SION Sold 1,890 shares at $44.57 · planned $0.1M Feb 2

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.